Ajanta Pharma has received a certificate confirming compliance with SEBI regulations concerning depositories and participants for the quarter ended September 30, 2025. The confirmation was received from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent. This certificate confirms the dematerialization of shares and adherence to regulatory guidelines, ensuring investor protection.

Confirmation of Depository Compliance

Ajanta Pharma has received confirmation regarding compliance with depository regulations. The certificate, provided by MUFG Intime India Private Limited, covers the quarter ending September 30, 2025. This confirms that all securities received for dematerialization have been duly processed.

Details of Compliance

The certificate confirms that the securities received from depository participants for dematerialization during the quarter ending September 30, 2025, were duly processed and confirmed. Additionally, it verifies that the security certificates received for dematerialization were mutilated and canceled after verification, with the depositories’ names substituted in the register of members within the prescribed timelines. This ensures adherence to regulatory standards and proper record-keeping of share ownership.

MUFG Intime India Confirmation

MUFG Intime India Private Limited, the Registrar and Share Transfer Agent, has confirmed that securities have been listed on the stock exchanges where the earlier issued securities are listed. This ensures compliance with listing requirements.

Source: BSE

Black Box Limited has received a certificate related to the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025. This certificate, issued by Datamatics Business Solution Limited, confirms compliance with regulatory requirements for handling dematerialized securities. The company has provided this information to stakeholders to ensure transparency and adherence to established guidelines.

Compliance Confirmation

Black Box Limited has announced the successful receipt of a certificate pertaining to compliance with the SEBI (Depositories and Participants) Regulations, 2018. The certificate covers the period ending September 30, 2025.

Certificate Details

The certificate was issued by Datamatics Business Solution Limited, who serve as the Registrar & Share Transfer Agent (‘RTA’) for Black Box Limited. This certificate ensures that all activities related to dematerialized securities are being managed in accordance with established regulatory guidelines. The company is disseminating this information to ensure all stakeholders are informed of their adherence to compliance standards.

Key Points of Certification

The certificate confirms that the securities received for dematerialization during the quarter ended September 30, 2025 are listed on both the Bombay Stock Exchange Limited (BSE) and the National Stock Exchange of India Limited (NSE). It also certifies that the certificates have been mutilated and cancelled after due verification and that the name of the depository has been properly substituted in the records.

Source: BSE

Birlasoft Ltd, part of the CKA Birla Group, has appointed Komal Jain as Chief Executive Officer (CEO) – Americas. Jain will lead Birlasoft’s business across the United States, Canada, Mexico, and Latin America, focusing on growth, client partnerships, and innovation. He brings over two decades of experience in technology, strategy, and sales, aiming to translate transformation into tangible outcomes.

New Leadership in the Americas

Birlasoft has announced the appointment of Komal Jain as the Chief Executive Officer (CEO) for the Americas region. The appointment, effective October 8, 2025, signifies Birlasoft’s commitment to strengthening its presence and driving growth in this key market.

Strategic Focus and Responsibilities

As CEO – Americas, Komal Jain will oversee Birlasoft’s operations across the United States, Canada, Mexico, and Latin America. His primary responsibilities will include accelerating business growth, strengthening relationships with existing clients, shaping the company’s innovation agenda, and spearheading strategic investments to enhance Birlasoft’s market leadership.

Executive Commentary

Angan Guha, CEO and Managing Director of Birlasoft, expressed his enthusiasm about the appointment: “We are delighted to welcome Komal to Birlasoft. His proven leadership, extensive industry expertise, and strong focus on innovation and client success will be instrumental in fueling our growth and unlocking new business opportunities across the Americas.”

Experience and Background

Komal Jain brings over two decades of leadership experience in technology, business strategy, sales, and global marketing. Prior to joining Birlasoft, he served as Senior Vice President and Head of the High-Tech, Media, and Entertainment vertical at Infosys. He holds a Master’s in Business Administration from the Indian Institute of Management, Calcutta, and a Bachelor’s degree in Electronics Engineering from the National Institute of Technology, Kurukshetra.

About Birlasoft

Birlasoft enables digital transformation through expertise in Cloud, AI, Data, and enterprise solutions. The company’s nearly 12,000 professionals drive innovation and focus on long-term value creation, transforming enterprises and communities.

Source: BSE

BEML Limited has issued a certificate under the SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended September 30, 2025. The certificate, received from KFin Technologies Limited, Registrar and Share Transfer Agent, ensures that all securities dematerialized/rematerialized during the quarter have been duly processed and reported to the stock exchanges. This announcement ensures regulatory adherence and transparency for investors.

Compliance Confirmation

BEML Limited has submitted a certificate confirming adherence to regulatory standards for the period ending September 30, 2025. This certificate is in accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Details of the Certificate

The certificate was received from M/s KFin Technologies Limited, the Registrar and Share Transfer Agent for BEML Limited. It confirms that all necessary procedures related to the dematerialization or rematerialization of securities during Q2 (July-September) of 2025 have been completed and reported to relevant stock exchanges as per regulatory requirements.

Source: BSE

CG Power and Industrial Solutions Limited has received a certificate confirming compliance with SEBI’s depository regulations. The certificate, issued by Datamatics Business Solutions Limited on October 7, 2025, pertains to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the period from July 1, 2025 to September 30, 2025. This confirms adherence to requirements for dematerialization of securities.

Depository Compliance Certificate Received

CG Power and Industrial Solutions Limited has announced the receipt of a compliance certificate concerning depository regulations. The certificate confirms adherence to specific requirements related to the handling of dematerialized securities.

Details of the Compliance Period

The certificate, issued by Datamatics Business Solutions Limited, covers the period from July 1, 2025, to September 30, 2025 (Q2 of fiscal year 2025-2026). It specifically addresses compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Confirmation of Regulatory Adherence

The certificate verifies that all securities of CG Power received for dematerialization during the quarter ended September 30, 2025, are listed on both the BSE Limited and the National Stock Exchange of India Limited. It also confirms that certificates of such securities have been mutilated and cancelled after due verification, and the name of the Depository has been substituted in the register of members within 15 days of receipt.

Source: BSE

Thermax Limited confirms compliance with SEBI regulations regarding dematerialization for the quarter ended September 30, 2025 (Q2 2026). Securities received for dematerialization have been mutilated and canceled after due verification. The depository’s name has been substituted in company records as the registered owner within 15 days of receiving the security certificate. Dematerialized securities are listed on the stock exchanges.

Dematerialization Compliance

Thermax Limited has confirmed adherence to regulatory guidelines concerning securities dematerialization for the fiscal quarter ending September 30, 2025. This certificate, dated October 8, 2025, assures that all procedures related to the conversion of physical shares to electronic form have been carried out as per the mandates.

Key Points of Compliance

The company, through its Registrar and Transfer Agent, KFin Technologies Limited, has verified and processed all securities received for dematerialization. The key steps undertaken include:

< >

* Mutilation and cancellation of securities after due verification.
* Substitution of the depository’s name in the company records within 15 days.

The details have been furnished to the stock exchanges where the company’s shares are listed, and the dematerialized securities are confirmed to be listed on those exchanges.

Source: BSE

Apollo Hospitals Enterprise Limited has issued a certificate confirming the dematerialization of securities for the quarter ended September 30, 2025. As per regulations, the details have been furnished to the Bombay Stock Exchange and the National Stock Exchange of India where the company’s shares are listed. The certificate confirms compliance with SEBI regulations.

Confirmation of Dematerialization

Apollo Hospitals Enterprise Limited has certified the details of securities dematerialized during the period ending September 30, 2025. This confirmation adheres to regulatory requirements concerning depositories and participants. The certificate confirms all necessary actions have been taken regarding the company’s listed shares.

Stock Exchange Listings

The details of the dematerialized securities have been provided to the following stock exchanges where Apollo Hospitals’ shares are listed:

Bombay Stock Exchange Limited.
National Stock Exchange of India Limited.

Integrated Registry Management Services Confirmation

Integrated Registry Management Services Private Limited confirms that securities received for dematerialization during the quarter ended September 30, 2025, were duly processed. They have verified the securities, updated records, and ensured compliance with regulations. The security certificates received for dematerialization have been mutilated and cancelled after due verification, and the name of the depositories have been substituted in register of members as the registered owner.

Source: BSE

BEML Limited has submitted the certificate received from M/s KFin Technologies Limited, Registrar and Share Transfer Agent of the Company for the quarter ended September 30, 2025. This submission is in accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This announcement confirms BEML’s adherence to regulatory compliance.

Regulatory Compliance Update

BEML Limited has confirmed its compliance with key regulatory requirements through the submission of a certificate pertaining to Depositories and Participants. The certificate, received from M/s KFin Technologies Limited, covers activities related to the Registrar and Share Transfer Agent for the company.

Certificate Details

This certificate confirms compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2025. The submission underscores BEML’s commitment to maintaining high standards of corporate governance.

Source: BSE

Concord Biotech announces the successful completion of the NAFDAC (National Agency for Food and Drug Administration) inspection at its Oral Solid Dosage (OSD) Unit-2 facility in Valthera, Gujarat. The inspection, conducted from October 06, 2025 to October 07, 2025, underscores Concord Biotech’s commitment to quality, safety, and regulatory compliance. This achievement reflects the company’s dedication to maintaining the highest standards.

NAFDAC Inspection Successfully Concluded

Concord Biotech is pleased to announce the successful completion of the NAFDAC inspection (National Agency for Food and Drug Administration) at their Oral Solid Dosage (OSD) Unit-2 facility located in Valthera, Gujarat. This positive outcome highlights the company’s adherence to international regulatory standards.

Inspection Details and Significance

The NAFDAC inspection was conducted over a two-day period, from October 06, 2025 to October 07, 2025. The successful completion of this inspection underscores Concord Biotech’s unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance in all its operations.

Commitment to Quality and Compliance

This achievement reflects Concord Biotech’s dedication to excellence and its continued focus on meeting the rigorous requirements of global regulatory authorities. The company remains committed to providing high-quality pharmaceutical products while adhering to the strictest regulatory guidelines.

Source: BSE